The number of people with susceptibility test result for rifampicin in Puerto Rico
Puerto Rico: The number of people with susceptibility test result for rifampicin was 14 in 2021. ▼ Falling
Latest (2021)
14
Change on year
down 36.4%
World rank
136th
of 155 countries
All-time high
30
in 2019
All-time low
14
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Puerto Rico, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Puerto Rico stood at 14. That is the lowest value across all 5 years on record.
The figure is down 36.4% on the previous year and down 51.7% over five years.
Puerto Rico ranks 136th of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Puerto Rico, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 29 | — |
| 2018 | 17 | -41.4% |
| 2019 | 30 | +76.5% |
| 2020 | 22 | -26.7% |
| 2021 | 14 | -36.4% |
Puerto Rico compared with similar countries
- Puerto Rico's 14 is below the median for high income countries, which is 142, 10% of the median. (61 countries reporting)
- Puerto Rico's 14 is below the median for Latin America & Caribbean, which is 406.5, 3% of the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 25.33 | 17 | 30 | 3 |
| 2020s | 18 | 14 | 22 | 2 |
Countries ranked near Puerto Rico
More health data for Puerto Rico
- Un projection of annual infant deaths, annual growth rate -20 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.45 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,519 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Population ages 00-04, female, annual growth rate -0.4804 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0145 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8484 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0152 units per person (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Puerto Rico?
- The number of people with susceptibility test result for rifampicin in Puerto Rico was 14 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Puerto Rico?
- The highest recorded value was 30 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Puerto Rico?
- The lowest recorded value was 14 in 2021.
- How does Puerto Rico rank for the number of people with susceptibility test result for rifampicin?
- Puerto Rico ranks 136th out of 155 countries with data for 2021.
- Where does this Puerto Rico data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).